@techcrunch.com 2 years ago
Flagship Pioneering’s new venture is betting on tRNA to treat “thousands of diseases”
@techcrunch.com 2 years ago
Biofourmis receives FDA breakthrough device designation for heart failure “digital therapy”
@xconomy.com 3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@tech.eu 3 years ago
Swiss medtech startup Bloom Diagnostics launches new testing system after €10 million Series B
@xconomy.com 4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further